Cholecystokinin Interneurons

Introduction

Cholecystokinin (CCK) interneurons represent a major population of cortical and hippocampal GABAergic inhibitory neurons characterized by their expression of the cholecystokinin peptide. These cells play crucial roles in regulating neuronal circuits involved in anxiety, memory, food intake, and pain perception. CCK interneurons are particularly vulnerable in neurodegenerative diseases, making them important therapeutic targets.

Overview

flowchart TD
    CCK["CCK"] -->|"interacts with"| Nucleus_Tractus_Solitarius["Nucleus Tractus Solitarius"]
    CCK["CCK"] -->|"biomarker for"| ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"]
    style CCK fill:#4fc3f7,stroke:#333,color:#000

Cholecystokinin interneurons are a subclass of basket cells that provide powerful perisomatic inhibition to pyramidal neurons. They are distinguished by their expression of CCK, a peptide hormone/neurotransmitter that acts on CCK receptors (CCK1R and CCK2R) throughout the brain

Molecular Markers

CCK interneurons can be identified by the following molecular markers:

• CCK (cholecystokinin) - primary peptide marker

• VIP (vasoactive intestinal peptide) - often co-expressed

• CB1R (cannabinoid receptor type 1) - high expression

• CR (calretinin) - partial co-expression

• nNOS (neuronal nitric oxide synthase) - subset expression

Anatomy

Distribution

CCK interneurons are distributed throughout:

• Cortex: Layers 2-6, with highest density in layers 2/3 and 5

• Hippocampus: Predominantly in stratum radiatum and stratum moleculare of CA1, and hilus of dentate gyrus

• Amygdala: Central and basolateral nuclei

• Basal ganglia: Striatum and nucleus accumbens

Morphology

These neurons exhibit:

• Basket cell morphology - dense axonal arborizations forming perisomatic synapses

• Bitufted or multipolar somata

• Long dendrites extending across multiple layers

• Extensive axonal networks targeting pyramidal neuron somata and proximal dendrites

Electrophysiology

CCK interneurons display distinct electrophysiological properties^{1Molecular and electrophysiological characterization of CCK basket cells. J Neurosci. 2009;29(44):13878-138892009 · DOI 10.1523/JNEUROSCI.3017-09.2009Open reference}:

• Late-spiking phenotype

• Adaptive firing patterns

• Low-threshold calcium spikes

• Depolarizing IPSPs due to CCK modulation

• Synaptic plasticity at CCK synapses sensitive to experience

Function

Perisomatic Inhibition

CCK basket cells provide powerful inhibition to pyramidal neuron cell bodies, regulating^{2Complementary roles of cholecystokinin- and parvalbumin-expressing GABAergic neurons in hippocampal network oscillations. J Neurosci. 2020;40(42):7990-80042020 · DOI 10.1523/JNEUROSCI.1027-20.2020Open reference}:

• Pyramidal neuron output - controlling action potential generation

• Network oscillations - influencing gamma and theta rhythms

• Memory consolidation - coordinating hippocampal-cortical communication

Anxiety and Fear Circuits

CCK systems play complex roles in anxiety^{3Cholecystokinin and anxiety: implications for the treatment of anxiety-related disorders. Neuropsychopharmacology. 2013;38(12):25052013 · DOI 10.1038/npp.2013.165Open reference}:

• CCK2R activation produces anxiogenic effects

• CCK1R activation modulates panic responses

• Bidirectional modulation of fear memory

Food Intake

CCK is a key satiety signal:

• CCK1R in vagal afferents reduces food intake

• Central CCK modulates appetite circuits

• Interaction with leptin in energy homeostasis

Role in Neurodegeneration

Alzheimer’s Disease

CCK interneurons are affected in AD through multiple mechanisms^{4Loss of CCK interneurons contributes to hippocampal network dysfunction in Alzheimer's disease. Nat Neurosci. 2023;26(3):387-3992023 · DOI 10.1038/s41593-023-01267-5Open reference}:

Circuit Dysfunction:

• Loss of CCK neurons correlates with memory impairment

• Reduced CCK release contributes to network hyperexcitability

• Amyloid-beta deposition preferentially affects CCK interneurons

Therapeutic Implications:

• CCK4 receptor agonists show promise in AD models

• CCK augmentation may restore inhibitory tone

• CB1R-CCK co-modulation is a potential target

Parkinson’s Disease

In PD, CCK systems contribute to non-motor symptoms^{5Cholecystokinin neurons in Parkinson's disease. Mov Disord. 2022;37(5):1023-10352022 · DOI 10.1002/mds.28958Open reference}:

Mood Disorders:

• CCK alterations associated with anxiety in PD

• Reduced CCK in substantia nigra pars reticulata

• CCK1R polymorphisms linked to PD depression

Cognitive Impairment:

• CCK dysfunction contributes to executive dysfunction

• Hippocampal CCK neuron loss affects spatial memory

• CCK-CB1 receptor interactions altered in PD^{6CCK and cannabinoid receptor interplay in the hippocampus. Brain Res Bull. 2021;176:141-1512021 · DOI 10.1016/j.brainresbull.2021.07.017Open reference}

Other Neurodegenerative Disorders

• Frontotemporal dementia: CCK neuron loss in frontal cortex

• Huntington’s disease: Early CCK interneuron degeneration

• Amyotrophic lateral sclerosis: CCK motor neuron interactions affected

Connectivity

Inputs

CCK interneurons receive input from:

• Pyramidal neurons - feedback excitation

• Other interneurons - disinhibition

• Subcortical modulators - serotonin, dopamine

Outputs

Their axonal projections target^{2Complementary roles of cholecystokinin- and parvalbumin-expressing GABAergic neurons in hippocampal network oscillations. J Neurosci. 2020;40(42):7990-80042020 · DOI 10.1523/JNEUROSCI.1027-20.2020Open reference}:

• Pyramidal neuron somata - perisomatic inhibition

• Other interneurons - disinhibitory circuits

• Local microcircuits - coordinate network activity

Therapeutic Targets

Receptor Agonists

• CCK1R agonists - potential for cognitive enhancement

• CCK2R modulators - anxiety treatment

Receptor Antagonists

• CCK2R antagonists - anxiogenic modulation

• Combined CCK-CB1 approaches^{6CCK and cannabinoid receptor interplay in the hippocampus. Brain Res Bull. 2021;176:141-1512021 · DOI 10.1016/j.brainresbull.2021.07.017Open reference}

Research Methods

• Electrophysiology - patch-clamp recordings^{1Molecular and electrophysiological characterization of CCK basket cells. J Neurosci. 2009;29(44):13878-138892009 · DOI 10.1523/JNEUROSCI.3017-09.2009Open reference}

• Optogenetics - channelrhodopsin targeting

• Transgenic mice - CCK-Cre lines

• Calcium imaging - population activity

• Cell Types Indexcell-types)

• GABAergic Neurons

• Basket Cells

• Alzheimer’s Disease

• Parkinson’s Disease

• Anxiety Disorders

Background

The study of Cholecystokinin Interneurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• PubMed - Biomedical literature

• Alzheimer’s Disease Neuroimaging Initiative - Research data

• Allen Brain Atlas - Brain gene expression data